Apostolia M Tsimberidou Selected Research

Pemetrexed (MTA)

2/2022	Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study.
12/2002	Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Apostolia M Tsimberidou Research Topics

Disease

120	Neoplasms (Cancer) 03/2024 - 09/2003
13	Neoplasm Metastasis (Metastasis) 08/2023 - 03/2009
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 01/2013
9	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 03/2011
8	Breast Neoplasms (Breast Cancer) 01/2024 - 02/2010
8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2017 - 04/2003
7	Fatigue 12/2023 - 04/2011
7	Melanoma (Melanoma, Malignant) 01/2021 - 01/2014
7	Thrombocytopenia (Thrombopenia) 01/2019 - 11/2010
6	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 12/2013
6	Hypertension (High Blood Pressure) 01/2021 - 01/2011
5	Exanthema (Rash) 12/2023 - 04/2011
5	Neutropenia 01/2023 - 11/2010
5	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 03/2011
4	Mucositis 12/2023 - 07/2011
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2023 - 03/2013
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 12/2002
4	Lymphoma (Lymphomas) 07/2006 - 02/2002
3	Endometrial Neoplasms (Endometrial Cancer) 02/2024 - 05/2014
3	Triple Negative Breast Neoplasms 01/2024 - 12/2014
3	Leiomyosarcoma 12/2023 - 12/2016
3	Infections 12/2023 - 10/2007
3	Residual Neoplasm 01/2020 - 02/2002
3	Disease Progression 01/2018 - 06/2016
3	Adenoid Cystic Carcinoma (Cylindroma) 01/2018 - 12/2013
3	Myocardial Infarction 07/2013 - 06/2005
2	Cholangiocarcinoma 01/2024 - 01/2013
2	Hyperglycemia 12/2023 - 01/2022
2	Diarrhea 12/2023 - 06/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2023 - 02/2023
2	Brain Neoplasms (Brain Tumor) 08/2023 - 01/2013
2	Carcinogenesis 03/2023 - 08/2018
2	Ovarian Epithelial Carcinoma 01/2023 - 06/2016
2	Nausea 01/2023 - 01/2022
2	Lung Neoplasms (Lung Cancer) 10/2019 - 05/2013

Drug/Important Bio-Agent (IBA)

19	Bevacizumab (Avastin)FDA Link 12/2023 - 09/2010
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2013
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2015 - 01/2008
10	fludarabineIBA 10/2013 - 02/2002
9	Biomarkers (Surrogate Marker)IBA 08/2023 - 03/2013
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2011
8	Cetuximab (Erbitux)FDA Link 01/2020 - 02/2013
7	Rituximab (Mabthera)FDA Link 11/2017 - 02/2002
7	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2013 - 04/2002
6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2011
6	MTOR InhibitorsIBA 01/2014 - 03/2012
5	temsirolimus FDA Link 12/2023 - 12/2013
5	Cell-Free Nucleic AcidsIBA 06/2020 - 01/2016
5	Monoclonal AntibodiesIBA 01/2020 - 10/2003
5	Lenalidomide (CC 5013)FDA Link 01/2018 - 12/2013
4	Hormones (Hormone)IBA 01/2024 - 12/2019
4	Paclitaxel (Taxol)FDA LinkGeneric 04/2023 - 07/2011
4	selinexorIBA 01/2023 - 01/2021
4	Circulating Tumor DNAIBA 01/2022 - 01/2018
4	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 04/2011
4	VemurafenibIBA 01/2021 - 12/2016
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 01/2013
4	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2004 - 02/2002
4	Dexamethasone (Maxidex)FDA LinkGeneric 04/2003 - 02/2002
3	Phosphotransferases (Kinase)IBA 01/2024 - 04/2011
3	CreatinineIBA 12/2023 - 10/2007
3	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2018
3	Carboplatin (JM8)FDA LinkGeneric 04/2023 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2018
3	Trastuzumab (Herceptin)FDA Link 01/2023 - 02/2015
3	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2018
3	Everolimus FDA Link 01/2021 - 05/2014
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 09/2003
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017 - 03/2009
3	Irinotecan (Camptosar)FDA LinkGeneric 12/2016 - 10/2013
3	Cisplatin (Platino)FDA LinkGeneric 10/2013 - 04/2002
3	Leucovorin (Folinic Acid)FDA Link 02/2013 - 09/2010
3	Fluorouracil (Carac)FDA LinkGeneric 02/2013 - 09/2010
3	Hemoglobins (Hemoglobin)IBA 03/2012 - 10/2007
3	Gemtuzumab (Mylotarg)FDA Link 06/2005 - 12/2002
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2024 - 06/2016
2	sapanisertibIBA 12/2023 - 04/2023
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2023 - 04/2023
2	HLA-A Antigens (HLA-A)IBA 12/2023 - 01/2023
2	Lipase (Acid Lipase)FDA Link 12/2023 - 04/2011
2	Valproic Acid (Depakote)FDA LinkGeneric 12/2023 - 04/2015
2	Chimeric Antigen ReceptorsIBA 10/2023 - 06/2020
2	human ERBB2 proteinIBA 08/2023 - 01/2019
2	Pemetrexed (MTA)FDA Link 02/2022 - 12/2002
2	CrizotinibIBA 01/2021 - 01/2018
2	pembrolizumabIBA 01/2021 - 01/2020
2	Proteasome InhibitorsIBA 01/2020 - 01/2019
2	Histone Deacetylase InhibitorsIBA 01/2020 - 10/2016
2	Vorinostat FDA Link 01/2020 - 10/2016
2	Transaminases (Aminotransferases)IBA 12/2019 - 12/2013
2	Alkaline PhosphataseIBA 12/2019 - 03/2009
2	IpilimumabIBA 01/2018 - 01/2018

Therapy/Procedure

81	Therapeutics 12/2023 - 12/2002
15	Drug Therapy (Chemotherapy) 01/2022 - 12/2002
13	Precision Medicine 03/2024 - 01/2013
10	Immunotherapy 01/2022 - 04/2015
4	Investigational Therapies (Experimental Therapy) 02/2023 - 05/2014
4	Time-to-Treatment 07/2017 - 02/2015
2	Radiotherapy 10/2023 - 01/2018
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 04/2015